INMODE LTD

INMD is the Nasdaq ticker symbol for InMode Ltd., an Israel-based medical device company. The stock represents equity ownership in the company, which develops and markets minimally invasive aesthetic and medical treatment platforms. INMD trades on the Nasdaq Global Select Market under this ticker, allowing investors to buy and sell shares during regular U.S. market hours.

InMode operates in the medical device industry, specifically within the aesthetic and minimally invasive treatment segment. Its platforms are used for procedures such as body contouring, skin rejuvenation, and women's health. The company competes in the broader healthcare equipment sector, combining radiofrequency and laser technologies to serve physicians and clinics globally.

Recent performance for INMD can be tracked through the price chart and key statistics on this page. Stock returns over various periods reflect factors such as quarterly results, guidance changes, and broader market conditions. For the latest price, percentage change, and historical trends, refer to the live INMD data displayed above.

Valuation can be assessed using metrics such as the price-to-earnings (P/E) ratio, price-to-sales (P/S), and enterprise value-to-EBITDA, compared with peers in the medical device sector. Analysts also consider growth rates, margins, and cash flow. Current valuation multiples for INMD are available in the financial summary section on this page.

To buy INMD shares, you need a brokerage account that offers access to U.S. markets. Once funded, you can place a market or limit order for INMD during regular trading hours (9:30 AM to 4:00 PM ET). Fractional shares may be available depending on your broker. Confirm any commissions or fees before trading.

Key risks include regulatory changes affecting medical device approvals, competition from other aesthetic technology providers, and dependence on international markets. Currency fluctuations, supply chain disruptions, and the pace of adoption by physicians can also impact results. Additionally, as a growth-oriented company, INMD may be sensitive to shifts in healthcare spending and economic conditions.